Link Pharma Chem

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE302F01011
  • NSEID:
  • BSEID: 524748
INR
26.80
-0.04 (-0.15%)
BSENSE

Nov 20

BSE+NSE Vol: 171

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 376687,
    "name": "Link Pharma Chem",
    "stock_name": "Link Pharma Chem",
    "full_name": "Link Pharma Chem Ltd",
    "name_url": "stocks-analysis/link-pharma-chem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.80",
    "chg": -0.04,
    "chgp": "-0.15%",
    "dir": -1,
    "prev_price": "26.84",
    "mcapval": "12.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524748,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE302F01011",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "171 ",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/link-pharma-chem-376687-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Link Pharma Chem Ltd Valuation Shifts Amidst Market Downturn",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-amidst-market-downturn-4265850",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/LinkPharmaChemL_valuationdot_4265850.png",
        "date": "2026-11-18 08:01:39",
        "description": "Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a sharp decline in its share price and deteriorating financial metrics, raising questions about its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Link Pharma Chem Ltd Valuation Shifts to Fair Amidst Steep Price Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-fair-amidst-steep-price-decline-4242624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LinkPharmaChemL_valuationdot_4242624.png",
        "date": "2026-10-29 08:00:25",
        "description": "Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a challenging market environment and deteriorating financial metrics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-attractive-amidst-challenging-market-returns-4234460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LinkPharmaChemL_valuationdot_4234460.png",
        "date": "2026-10-23 08:00:45",
        "description": "Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite persistent headwinds reflected in its financial performance and market returns, the stock’s price-to-book value and other valuation metrics suggest a potential reappraisal of its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-attractive-amidst-challenging-market-returns-4215054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LinkPharmaChemL_valuationdot_4215054.png",
        "date": "2026-10-06 08:00:29",
        "description": "Link Pharma Chem Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade despite persistent operational challenges and a micro-cap status. This article analyses the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to its historical averages and peer group, providing investors with a comprehensive view of its price attractiveness and underlying risks."
      },
      {
        "title": "Link Pharma Chem Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-signal-renewed-price-attractiveness-4198955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LinkPharmaChemL_valuationdot_4198955.png",
        "date": "2026-09-21 08:00:26",
        "description": "Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite ongoing operational challenges reflected in its financial metrics, the stock’s price-to-book value and other valuation multiples suggest a potentially compelling entry point for investors willing to navigate the risks inherent in this segment."
      },
      {
        "title": "Link Pharma Chem Ltd Valuation Shifts to Fair Amidst Volatile Market Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-fair-amidst-volatile-market-performance-4168158",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LinkPharmaChemL_valuationdot_4168158.png",
        "date": "2026-08-25 08:00:30",
        "description": "Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen its valuation grade downgraded from attractive to fair, reflecting a notable shift in price attractiveness despite a recent uptick in its share price. This change comes amid a backdrop of challenging financial metrics and a mixed performance relative to the broader market and peers."
      }
    ],
    "total": 43,
    "sid": "376687",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/link-pharma-chem-376687"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Nov-2026",
      "details": "Newspaper publication of Unaudited Financial Results of the Company for Quarter and Half year ended September 30 2026 in Business standard (English Edition) and Loksatta (Gujarati Edition).",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results Of The Board Meeting Held On 3Rd November 2026",
      "datetime": "03-Nov-2026",
      "details": "Unaudited Financial results of the Board meeting held on 3rd November 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome Of Board Meeting Held On 3Rd November 2026",
      "datetime": "03-Nov-2026",
      "details": "Board meeting outcome of Board Meeting held on 3rd November 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

04-Nov-2026 | Source : BSE

Newspaper publication of Unaudited Financial Results of the Company for Quarter and Half year ended September 30 2026 in Business standard (English Edition) and Loksatta (Gujarati Edition).

Unaudited Financial Results Of The Board Meeting Held On 3Rd November 2026

03-Nov-2026 | Source : BSE

Unaudited Financial results of the Board meeting held on 3rd November 2026

Board Meeting Outcome for Board Meeting Outcome Of Board Meeting Held On 3Rd November 2026

03-Nov-2026 | Source : BSE

Board meeting outcome of Board Meeting held on 3rd November 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available